WO1999043332A8 - Combinaison anti-tumeur comprenant de l'epirubicine et de la gemcitabine pour le traitement du cancer des poumons n'etant pas du type a petites cellules - Google Patents

Combinaison anti-tumeur comprenant de l'epirubicine et de la gemcitabine pour le traitement du cancer des poumons n'etant pas du type a petites cellules

Info

Publication number
WO1999043332A8
WO1999043332A8 PCT/EP1999/001283 EP9901283W WO9943332A8 WO 1999043332 A8 WO1999043332 A8 WO 1999043332A8 EP 9901283 W EP9901283 W EP 9901283W WO 9943332 A8 WO9943332 A8 WO 9943332A8
Authority
WO
WIPO (PCT)
Prior art keywords
epirubicin
gemcitabine
treatment
small
lung cancer
Prior art date
Application number
PCT/EP1999/001283
Other languages
English (en)
Other versions
WO1999043332A1 (fr
Inventor
Marcello Riggi
Jan Smeets
Hendricus Groen
Putten Jan Van
Original Assignee
Pharmacia & Upjohn Spa
Marcello Riggi
Jan Smeets
Hendricus Groen
Putten Jan Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa, Marcello Riggi, Jan Smeets, Hendricus Groen, Putten Jan Van filed Critical Pharmacia & Upjohn Spa
Priority to AU30309/99A priority Critical patent/AU3030999A/en
Publication of WO1999043332A1 publication Critical patent/WO1999043332A1/fr
Publication of WO1999043332A8 publication Critical patent/WO1999043332A8/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne l'utilisation d'épirubicine dans la préparation d'un médicament pour l'administration concomitante ou séquentielle d'épirubicine avec de la gemcitabine, pour le traitement du cancer des poumons n'étant pas du type à petites cellules.
PCT/EP1999/001283 1998-02-26 1999-02-24 Combinaison anti-tumeur comprenant de l'epirubicine et de la gemcitabine pour le traitement du cancer des poumons n'etant pas du type a petites cellules WO1999043332A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU30309/99A AU3030999A (en) 1998-02-26 1999-02-24 Antitumor combination for the treatment of non-small-cell lung cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9804151.0 1998-02-26
GBGB9804151.0A GB9804151D0 (en) 1998-02-26 1998-02-26 Antitumor combination for the treatment of non-small-cell lung cancer

Publications (2)

Publication Number Publication Date
WO1999043332A1 WO1999043332A1 (fr) 1999-09-02
WO1999043332A8 true WO1999043332A8 (fr) 1999-10-14

Family

ID=10827675

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1999/001283 WO1999043332A1 (fr) 1998-02-26 1999-02-24 Combinaison anti-tumeur comprenant de l'epirubicine et de la gemcitabine pour le traitement du cancer des poumons n'etant pas du type a petites cellules

Country Status (3)

Country Link
AU (1) AU3030999A (fr)
GB (1) GB9804151D0 (fr)
WO (1) WO1999043332A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006032136A1 (fr) * 2004-09-20 2006-03-30 British Columbia Cancer Agency Branch Gemcitabine libre ou encapsulee dans des liposomes seule ou en association avec de l'idarubicine libre ou encapsulee dans des liposomes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021938A1 (fr) * 1992-05-04 1993-11-11 Adria Laboratories Procedes de traitement du cancer au moyen de l'epirubicine a haute dose

Also Published As

Publication number Publication date
GB9804151D0 (en) 1998-04-22
WO1999043332A1 (fr) 1999-09-02
AU3030999A (en) 1999-09-15

Similar Documents

Publication Publication Date Title
AU4133096A (en) Taxoid derivatives, their preparation and their use as antitumor agents
AU679663B2 (en) Dermatological or pharmaceutical composition, preparation process and use
WO2006046080A8 (fr) Traitements anticancereux
EP1072266B8 (fr) Thienylazolylalcoxyethanamines, leur preparation et leur application en tant que medicaments
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
AU5835098A (en) Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures
HK1033278A1 (en) Pharmaceutical preparation for use in anti-asthma therapy.
WO2002047668A3 (fr) Nouvelles compositions medicamenteuses a base d'anticholinergiques et de ciclesonide
AU9018898A (en) Phosphazole-containing nucleoside analogs, related compounds, pharmaceutical compositions thereof, and their use in in vitro medicinal treatments
ZA971659B (en) Erythromycin derivatives, their preparation process and their use as medicaments.
AU2874099A (en) Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
WO2001062235A3 (fr) Composition comprenant la camptothecine et un derive de pyrimidine et destinee a etre utilisee dans le traitement du cancer
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
HUP0100927A3 (en) Antitumor substituted indene-derivatives, process for their preparation, medicaments containing them and their use
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
CA2213099A1 (fr) Complexes de s-(+)-adenosyl-methionine et de 3'-azido-2',3'-didesoxy-nucleoside, puissants inhibiteurs de la replication du vih
WO1999043332A8 (fr) Combinaison anti-tumeur comprenant de l'epirubicine et de la gemcitabine pour le traitement du cancer des poumons n'etant pas du type a petites cellules
WO2003047697A3 (fr) Methodes de traitement du cancer utilisant un inhibiteur de farnesyl transferase (fpt) et des agents antineoplasiques
HUP0201810A2 (en) Sootepenseone and its derivatives, their preparation and use as medicament
ZA966616B (en) Benzenesulphonamide derivatives, their preparation and their application in theraphy.
AU8028600A (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine
AU3262697A (en) Combinations comprising vx478, zidovudine and/or 1592u89 for use in the treatment of hiv
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
WO2001040241A3 (fr) Derives de ketolide substitues par 6-o-alkyl-2-nor-2-

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: C1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 35/99 UNDER (54) THE TITLE SHOULD READ "ANTITUMOR COMBINATION COMPRISING EPIRUBICIN AND GEMCITABINE FOR THE TREATMENT OF NON-SMALL-CELL LUNG CANCER"

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: KR

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase in:

Ref country code: CA

122 Ep: pct application non-entry in european phase